Skip to content

Effect of tDCS in treatment of chronic pelvic pain due to endometriosis

Clinical Trial Investigating the Effects of tDCS on Symptoms in Patients with Chronic Pelvic Pain Due to Endometriosis Compared to Sham tDCS

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20151020024621N10
Enrollment
38
Registered
2025-05-18
Start date
2025-06-22
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic pelvic pain. Pelvic and perineal pain

Interventions

Intervention 1: Intervention group: Active tDCS Group: •Device: Transcranial Direct Current Stimulation (tDCS) • Stimulation Parameters: Intensity of 2 mA, each session lasting 20 minutes, three sessi

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Women aged 18-45 years Diagnosed by a gynecologist with chronic pelvic pain due to endometriosis Initial pain intensity based on a visual analog scale (VAS) greater than or equal to 4 Pain duration of at least 6 months Willingness to provide informed consent Consistent medication use for one month prior to trial start and failure to respond to drug therapy

Exclusion criteria

Exclusion criteria: History of other chronic pain conditions Neurological or psychiatric disorders Pregnant or lactating women Contraindications to tDCS use (e.g., metal implants in the head, active epilepsy)

Design outcomes

Primary

MeasureTime frame
Change in pain intensity, measured by visual analog scale. Timepoint: At the beginning of the study (before treatment), at each of the 6 treatment sessions (to assess immediate changes in pain), 2 months, and 4 months after completion of treatment. Method of measurement: Questioning patients and recording scores on a visual analog scale.

Secondary

MeasureTime frame
Changes in Endometriosis Health Profile Scores-30. Timepoint: At the beginning of the study (to establish a baseline of the patients' quality of life status), 2 months after the end of treatment (to assess the effect of treatment on quality of life). Method of measurement: Endometriosis health profile -30 Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactTannaz Ahadi

Iran University of Medical Sciences

tannaz.ahadi@yahoo.com+98 21 8214 1000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026